Arena Pharmaceuticals Profit Margin

Arena Pharmaceuticals (ARNA) currently reports a profit margin of -1141542.59% as of December 2021. That compares with -126875.86% in the prior-year period — down 799.7% year over year. That is below the Healthcare sector average of 14.34%. Use the charts on this page to explore Arena Pharmaceuticals's profit margin history and peer comparisons.

Arena Pharmaceuticals's profit margin decreased from -126875.86% to -1141542.59% — a 799.7% year-over-year decrease (period ending December 2021). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Arena Pharmaceuticals's profit margin of -1141542.59% is lower than the Healthcare sector average of 14.34%. That is roughly 7957995.2% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but Arena Pharmaceuticals's current -1141542.59% should be judged against Healthcare norms (sector average: 14.34%) and against ARNA's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of -1141542.59%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 14.34%. From there, open related valuation or income-statement pages for Arena Pharmaceuticals, and consider following ARNA for alerts when major investors trade the stock.